Xin Tian

7.3k total citations · 2 hit papers
181 papers, 4.3k citations indexed

About

Xin Tian is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Xin Tian has authored 181 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Genetics, 44 papers in Hematology and 31 papers in Immunology. Recurrent topics in Xin Tian's work include Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (21 papers) and Hematopoietic Stem Cell Transplantation (21 papers). Xin Tian is often cited by papers focused on Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (21 papers) and Hematopoietic Stem Cell Transplantation (21 papers). Xin Tian collaborates with scholars based in United States, China and Canada. Xin Tian's co-authors include Karen M. Schaich, Jianhua Xie, Adrian Wiestner, Mohammed Farooqui, Colin O. Wu, Susan Soto, Inhye E. Ahn, Janet Valdez, Michaël Domanski and Gregory J. Kato and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xin Tian

169 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hurdles and pitfalls in measuring antioxidant efficacy: A critical evaluation of ABTS, DPPH, and ORAC assays

2015 456 citations Xin Tian et al. profile →
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk

2020 211 citations Michaël Domanski, Xin Tian et al. profile →

Peers

Countries citing papers authored by Xin Tian

Since Specialization

Citations

This map shows the geographic impact of Xin Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Tian more than expected).

Fields of papers citing papers by Xin Tian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Tian. The network helps show where Xin Tian may publish in the future.

Co-authorship network of co-authors of Xin Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Tian. A scholar is included among the top collaborators of Xin Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Tian. Xin Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	REMOVED: Interim Results of a Phase II Trial of Omidubicel, Ex-Vivo Expanded Umbilical Cord Blood Transplantation in Patients with Treatment-Refractory Severe Aplastic Anemia 2025 ·Transplantation and Cellular Therapy ·Richard Childs, Xin Tian, Georg Aue, Neal S. Young, Raquel Ríos, Jian Hur, Jennifer Wilder, Kristen Cole, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Robert Reger	2
2	SARS-CoV-2 Immune Complex–Mediated Neutrophil Activation 2025 ·Open Forum Infectious Diseases ·(unknown), (unknown), Heather Teague, Marcos J. Ramos-Benítez, (unknown), Xin Tian, Robert Reger, Peter D. Burbelo, (unknown), Yogendra Kanthi, Jeffrey I. Cohen, (unknown), Anthony F. Suffredini, Christopher S. King, Steven D. Nathan, Richard Childs, Daniel S. Chertow, Jeffrey R. Strich	2
3	A Decade of Ibrutinib for CLL with and without TP53 Aberration: Final Report on an Investigator-Sponsored Phase 2 Study 2025 ·Blood ·(unknown), (unknown), (unknown), Constance M. Yuan, Hao‐Wei Wang, Inhye E. Ahn, Mohammed Farooqui, Xin Tian, Clare Sun, (unknown), Susan Soto, Jeanine Superata, (unknown), Thomas E. Hughes, Pia Nierman, Adrian Wiestner	0
4	Donor-derived cell-free DNA is associated with the degree of immunosuppression in lung transplantation 2025 ·American Journal of Transplantation ·(unknown), Moon Kyoo Jang, Hyesik Kong, Woojin Park, Xin Tian, Michael Keller, (unknown), (unknown), (unknown), (unknown), Shambhu Aryal, Gerald J. Berry, Charles C. Marboe, Jonathan B. Orens, Steven D. Nathan, Sean Agbor-Enoh	1
5	N6-methyladenosine demethylase FTO regulates neuronal oxidative stress via YTHDC1-ATF3 axis in arsenic-induced cognitive dysfunction 2024 ·Journal of Hazardous Materials ·Lixiao Zhou, Renjie Li, Fu Wang, Ruiqi Zhou, Yinyin Xia, Xuejun Jiang, Shuqun Cheng, (unknown), Danyang Li, Jun Zhang, (unknown), (unknown), Hongyang Zhang, Jingfu Qiu, Xin Tian, Zhen Zou, Chengzhi Chen	6
6	Serum insulin-like growth factor-1 as a potential prognostic biomarker for heart failure with reduced ejection fraction: a meta-analysis 2024 ·Frontiers in Cardiovascular Medicine ·Tingting Liu, Fangyu Li, (unknown), Fangling Sun, Mengqi Chen, Xin Tian, Wenrong Zheng, Zixin Zhu, Wen Wang	1
7	Uniform Graft-versus-Host Disease Prophylaxis using Post-Transplantation Cyclophosphamide, Methotrexate, and Cyclosporine following Peripheral Blood Hematopoietic Stem Cell Transplantation from Matched and Haploidentical Donors for Transfusion-Dependent Thalassemia: A Retrospective Report from the Bone Marrow Failure Working Group of Hunan Province, China 2024 ·Transplantation and Cellular Therapy ·(unknown), Xin Tian, (unknown), Liangchun Yang, Zhiming Wang, (unknown), Keke Chen, (unknown), (unknown), Xiaoyang Yang, (unknown), Bin Fu	0
8	Redefining Cardiac Antibody-Mediated Rejection With Donor-Specific Antibodies and Graft Dysfunction 2024 ·Circulation Heart Failure ·(unknown), Xin Tian, (unknown), (unknown), (unknown), (unknown), Moon Kyoo Jang, Hyesik Kong, T. Andargie, (unknown), Samer S. Najjar, (unknown), Keyur B. Shah, Steven Hsu, M.E. Rodrigo, Charles C. Marboe, Gerald J. Berry, Hannah A. Valantine, Palak Shah, Sean Agbor-Enoh	5
9	The role of the right atrial appendage and right atrium in post-radiofrequency ablation recurrence in different types of atrial fibrillation 2024 ·Clinical Radiology ·Tao Pan, Xin Tian, Yang Liu, (unknown), (unknown), (unknown), Chung‐Yi Li	1
10	5-Year Outcomes of Anterior Mitral Leaflet Laceration to Prevent Outflow Obstruction 2024 ·JACC: Cardiovascular Interventions ·Jaffar M. Khan, Vasilis Babaliaros, Adam B. Greenbaum, James M. McCabe, Toby Rogers, Marvin H. Eng, Jason Foerst, Shahram Yazdani, Gaetano Paone, Patrick Gleason, Rim Halaby, Christopher G. Bruce, Xin Tian, Annette M. Stine, Robert J. Lederman	4
11	Reduced Prefrontal-Thalamic Theta Flow During Working Memory Retrieval in APP/PS1 Mice 2024 ·Journal of Alzheimer s Disease ·Shengnan Zhang, (unknown), Jia Wang, Tiaotiao Liu, (unknown), Xin Tian, (unknown)	0
12	CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy 2023 ·Clinical Cancer Research ·(unknown), Jonathan Chen, Erika M. Gaglione, Chingiz Underbayev, Pamela L. Tuma, Xin Tian, Lita A. Freeman, Sivasubramanian Baskar, Pia Nierman, Susan Soto, (unknown), Inhye E. Ahn, Clare Sun, Elena Bibikova, Tanja Nicole Hartmann, (unknown), Adrian Wiestner	11
13	Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome 2021 ·British Journal of Haematology ·Richard Childs, Xin Tian, (unknown), Enkhtsetseg Purev, Ritesh R. Kotecha, Mattias Carlsten, Joseph Clara, Willy A. Flegel, Sharon Adams, Hanh Khuu, David F. Stroncek, Lisa Cook, Tatyana Worthy, Nancy L. Geller, (unknown), Jennifer Wilder, Robert Reger, Georg Aue	4
14	Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib 2021 ·Clinical Cancer Research ·Christian Brieghel, (unknown), (unknown), Michael Asger Andersen, Christina W. Yde, Xin Tian, Adrian Wiestner, Inhye E. Ahn, Carsten Utoft Niemann	24
15	Association of Cumulative Systolic Blood Pressure With Long-Term Risk of Cardiovascular Disease and Healthy Longevity 2020 ·Hypertension ·Orna Reges, Hongyan Ning, John T. Wilkins, Colin O. Wu, Xin Tian, Michaël Domanski, Donald M. Lloyd‐Jones, Norrina B. Allen	54
16	Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model 2020 ·Journal of Clinical Oncology ·Inhye E. Ahn, Xin Tian, David Ipe, Mei Cheng, Maher Albitar, L. Claire Tsao, Lei Zhang, Wanlong Ma, Sarah E.M. Herman, Erika M. Gaglione, Susan Soto, James P. Dean, Adrian Wiestner	56
17	A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo‐immunized patients 2020 ·British Journal of Haematology ·(unknown), Enkhtsetseg Purev, Kamille A. West, (unknown), Tatyana Worthy, Lisa Cook, (unknown), (unknown), (unknown), Willy A. Flegel, Sharon Adams, Robert Reger, Georg Aue, Xin Tian, Richard Childs	17
18	Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia 2018 ·The Journal of Immunology ·Georg Aue, Clare Sun, Delong Liu, Jae‐Hyun Park, Stefania Pittaluga, Xin Tian, Elinor Lee, Susan Soto, Janet Valdez, Irina Marić, Maryalice Stetler‐Stevenson, Constance M. Yuan, Yusuke Nakamura, Pawel Muranski, Adrian Wiestner	21
19	Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma 2016 ·Blood ·Nakhle S. Saba, Delong Liu, Sarah E. M. Herman, Chingiz Underbayev, Xin Tian, (unknown), Marc A. Weniger, Martin Skarzynski, (unknown), Lorena Fontán, Ari Melnick, Clíona Grant, Mark Roschewski, Alba Navarro, Sı́lvia Beà, Stefania Pittaluga, Kieron Dunleavy, Wyndham H. Wilson, Adrian Wiestner	111
20	On the Effect of Coordinate System Transformation by Selecting Seven Parameters of Different Spatial Domain 2015 ·Bulletin of Surveying and Mapping ·Xin Tian, (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact